Table of Contents
The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Therapeutic cancer peptide therapeutics in total represent a considerable market size of more than US$ 8 bln in the year 2013. Major cancer peptide products are of the classes of somatostatin analogs and agonists and antagonists of the gonadotropin releasing hormone (GnRH), but also of targeted cancer therapy including proteasome and HDAC inhibition.
The report provides a compilation of currently major marketed peptide cancer products and active projects in research and development for novel cancer peptides. Competitor projects are listed in a tabular format providing information on:
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the ...
The Global market for Hormone Replacement Therapy (HRT) Market is expected to reach $XX by the end of 2020 growing at a CAGR of around XX% from 2015 to 2021. Hormone Replacement therapy is the management ...
China’s demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a ...